Accretive Health
AH
AH was delisted on the 14th of March, 2014.
6 hedge funds and large institutions have $18.8M invested in Accretive Health in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 6 → 6 (0)
4% less capital invested
Capital invested by funds: $19.7M → $18.8M (-$871K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$2.05M |
| 2 |
LM
Litespeed Management
New York
|
+$1.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$39.5K |
AH Hedge Fund Activity: Q2 2016 in Review
6 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q2 2016, worth a combined $18.8M — down 4.4% from $19.7M a quarter earlier.
Fund positioning in AH was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Paradigm Capital Management Inc, adding an estimated $2.05M. The largest seller was Neuberger Berman Group, cutting an estimated $39.5K.
- 6 institutional investors held Accretive Health (AH) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $18.8M of Accretive Health stock for Q2 2016, down 4.4% quarter-over-quarter.
- 0 funds opened new Accretive Health positions in Q2 2016 and 0 closed out.
- The largest Accretive Health buyer in Q2 2016 was Paradigm Capital Management Inc, an estimated $2.05M added.
- The largest Accretive Health seller in Q2 2016 was Neuberger Berman Group, an estimated $39.5K sold.
Based on aggregated 13F filings for Q2 2016.